rs2303995

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004519.4(KCNQ3):​c.1241A>G​(p.Glu414Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0271 in 1,611,190 control chromosomes in the GnomAD database, including 1,347 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 134 hom., cov: 33)
Exomes 𝑓: 0.027 ( 1213 hom. )

Consequence

KCNQ3
NM_004519.4 missense

Scores

6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 3.49

Publications

21 publications found
Variant links:
Genes affected
KCNQ3 (HGNC:6297): (potassium voltage-gated channel subfamily Q member 3) This gene encodes a protein that functions in the regulation of neuronal excitability. The encoded protein forms an M-channel by associating with the products of the related KCNQ2 or KCNQ5 genes, which both encode integral membrane proteins. M-channel currents are inhibited by M1 muscarinic acetylcholine receptors and are activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 2 (BFNC2), also known as epilepsy, benign neonatal type 2 (EBN2). Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
KCNQ3 Gene-Disease associations (from GenCC):
  • seizures, benign familial neonatal, 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign neonatal seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017500818).
BP6
Variant 8-132163489-T-C is Benign according to our data. Variant chr8-132163489-T-C is described in ClinVar as Benign. ClinVar VariationId is 21409.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.165 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ3NM_004519.4 linkc.1241A>G p.Glu414Gly missense_variant Exon 9 of 15 ENST00000388996.10 NP_004510.1 O43525-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ3ENST00000388996.10 linkc.1241A>G p.Glu414Gly missense_variant Exon 9 of 15 1 NM_004519.4 ENSP00000373648.3 O43525-1

Frequencies

GnomAD3 genomes
AF:
0.0247
AC:
3752
AN:
152188
Hom.:
136
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00478
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0255
Gnomad ASJ
AF:
0.0219
Gnomad EAS
AF:
0.174
Gnomad SAS
AF:
0.0242
Gnomad FIN
AF:
0.0361
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0241
Gnomad OTH
AF:
0.0205
GnomAD2 exomes
AF:
0.0354
AC:
8886
AN:
251066
AF XY:
0.0338
show subpopulations
Gnomad AFR exome
AF:
0.00302
Gnomad AMR exome
AF:
0.0412
Gnomad ASJ exome
AF:
0.0255
Gnomad EAS exome
AF:
0.170
Gnomad FIN exome
AF:
0.0371
Gnomad NFE exome
AF:
0.0224
Gnomad OTH exome
AF:
0.0276
GnomAD4 exome
AF:
0.0273
AC:
39844
AN:
1458882
Hom.:
1213
Cov.:
29
AF XY:
0.0270
AC XY:
19573
AN XY:
726072
show subpopulations
African (AFR)
AF:
0.00305
AC:
102
AN:
33444
American (AMR)
AF:
0.0396
AC:
1770
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0255
AC:
667
AN:
26110
East Asian (EAS)
AF:
0.200
AC:
7940
AN:
39634
South Asian (SAS)
AF:
0.0169
AC:
1461
AN:
86200
European-Finnish (FIN)
AF:
0.0365
AC:
1947
AN:
53392
Middle Eastern (MID)
AF:
0.00729
AC:
42
AN:
5764
European-Non Finnish (NFE)
AF:
0.0219
AC:
24304
AN:
1109340
Other (OTH)
AF:
0.0267
AC:
1611
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
1750
3501
5251
7002
8752
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
980
1960
2940
3920
4900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0246
AC:
3747
AN:
152308
Hom.:
134
Cov.:
33
AF XY:
0.0267
AC XY:
1985
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.00476
AC:
198
AN:
41576
American (AMR)
AF:
0.0254
AC:
388
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0219
AC:
76
AN:
3470
East Asian (EAS)
AF:
0.175
AC:
904
AN:
5178
South Asian (SAS)
AF:
0.0238
AC:
115
AN:
4824
European-Finnish (FIN)
AF:
0.0361
AC:
383
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0241
AC:
1642
AN:
68020
Other (OTH)
AF:
0.0194
AC:
41
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
177
354
532
709
886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0265
Hom.:
314
Bravo
AF:
0.0238
TwinsUK
AF:
0.0208
AC:
77
ALSPAC
AF:
0.0210
AC:
81
ESP6500AA
AF:
0.00340
AC:
15
ESP6500EA
AF:
0.0224
AC:
193
ExAC
AF:
0.0340
AC:
4126
Asia WGS
AF:
0.0780
AC:
271
AN:
3478
EpiCase
AF:
0.0198
EpiControl
AF:
0.0210

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 17, 2012
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Seizures, benign familial neonatal, 2 Benign:1Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Inborn genetic diseases Benign:1
Apr 15, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Benign Neonatal Epilepsy Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Benign neonatal seizures Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Uncertain
-0.030
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.56
D;.;.;.;.
Eigen
Benign
-0.024
Eigen_PC
Benign
0.11
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.55
T;T;T;T;T
MetaRNN
Benign
0.0018
T;T;T;T;T
MetaSVM
Benign
-0.48
T
PhyloP100
3.5
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-3.1
D;.;D;D;.
REVEL
Uncertain
0.35
Sift
Benign
0.032
D;.;D;D;.
Sift4G
Benign
0.14
T;T;T;T;.
Polyphen
0.12
B;.;.;B;.
Vest4
0.50
MPC
1.1
ClinPred
0.019
T
GERP RS
4.6
Varity_R
0.20
gMVP
0.70
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2303995; hg19: chr8-133175736; COSMIC: COSV66474926; API